Entering to the U.S. market will be visualize as 10 companies are undergoing challenges to get FDA’s approvals

Korean pharmaceutical companies will hit stride in their global challenges targeting the U.S. market.

As the impotency drug that Mezzion, a new drug development company, made partnership with Actavis is expected to be approved by FDA next year, new drugs, such as a blood product of Green Cross, a new diabetes drug of LG, a botulinum product of Daewoong, an extreme obesity medicine of Chong Kun...